Thailand - Delayed Quote THB

The Klinique Medical Clinic Public Company Limited (KLINIQ.BK)

38.75 -0.25 (-0.64%)
At close: May 17 at 4:39 PM GMT+7
Loading Chart for KLINIQ.BK
DELL
  • Previous Close 39.00
  • Open 39.50
  • Bid --
  • Ask --
  • Day's Range 38.75 - 39.50
  • 52 Week Range 34.00 - 45.25
  • Volume 359,433
  • Avg. Volume 643,042
  • Market Cap (intraday) 8.525B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 29.58
  • EPS (TTM) 1.31
  • Earnings Date --
  • Forward Dividend & Yield 1.80 (4.65%)
  • Ex-Dividend Date Apr 10, 2024
  • 1y Target Est 42.90

The Klinique Medical Clinic Public Company Limited provides skin medical treatment services under the Klinique brand name in Thailand. Its services include face lift, acne and acne scars, skin tightening, filler, fat dissolving injection, laser hair removal, skin treatment, skin injection, Mesoface, and Mesotua, as well as nose, eye, and facial surgery. The company sells cosmetics and cosmeceutical products. The Klinique Medical Clinic Public Company Limited was incorporated in 2017 and is based in Bangkok, Thailand.

www.theklinique.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KLINIQ.BK

Performance Overview: KLINIQ.BK

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

KLINIQ.BK
5.93%
MSCI WORLD
9.57%

1-Year Return

KLINIQ.BK
2.18%
MSCI WORLD
23.91%

3-Year Return

KLINIQ.BK
7.64%
MSCI WORLD
37.06%

5-Year Return

KLINIQ.BK
7.64%
MSCI WORLD
37.06%

Compare To: KLINIQ.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KLINIQ.BK

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    8.53B

  • Enterprise Value

    7.82B

  • Trailing P/E

    29.58

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.73

  • Price/Book (mrq)

    5.01

  • Enterprise Value/Revenue

    3.42

  • Enterprise Value/EBITDA

    13.96

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.63%

  • Return on Assets (ttm)

    7.94%

  • Return on Equity (ttm)

    17.24%

  • Revenue (ttm)

    2.28B

  • Net Income Avi to Common (ttm)

    288.62M

  • Diluted EPS (ttm)

    1.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.17B

  • Total Debt/Equity (mrq)

    27.10%

  • Levered Free Cash Flow (ttm)

    -20.98M

Research Analysis: KLINIQ.BK

Company Insights: KLINIQ.BK

Research Reports: KLINIQ.BK

People Also Watch